Latest News

Date Title Topic
03 Feb 2015 Large Study Catalogues Genetic Alterations in Head and Neck Squamous Cell Carcinomas Translational research - Head and neck cancers
02 Feb 2015 FDA Expands Approved Use of Ibrutinib to Waldenström’s Macroglobulinaemia Haematologic malignancies - Anticancer agents & Biologic therapy
29 Jan 2015 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Ruxolitinib Haematologic malignancies - Anticancer agents & Biologic therapy
27 Jan 2015 Annals of Oncology Press Release: Lung Cancer Predicted to Overtake Breast Cancer as Leading Cause of Cancer Death Among European Women in 2015 Lung and other thoracic tumours
26 Jan 2015 ESMO Press Release: ESMO Delivers on Dynamic Force Strategy to Improve Cancer Research in Europe Bioethics, legal and economic issues
26 Jan 2015 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Protein Bound Paclitaxel Lung and other thoracic tumours - Anticancer agents & Biologic therapy
22 Jan 2015 Successful Implementation of SPECTAcolor, the First Pan-European and EORTC Screening Platform, Proves that a Logistically Complex Infrastructure to Run Next Generation Trials in a Multinational Setting is Feasible Personalised medicine - Translational research - Gastrointestinal cancers
ESMO – ACP
ESMO – SLO
20 Jan 2015 First-Line FOLFOXIRI/Bevacizumab Improves Long-Term Outcomes in Metastatic Colorectal Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
19 Jan 2015 Second-Line Treatment with FOLFIRI/Ramucirumab Delays Disease Progression and Extends Overall Survival in Patients With Metastatic Colorectal Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
16 Jan 2015 Next Generation Sequencing Reveals Genetic Landscape of Breast Phyllodes Tumours Breast cancer - Translational research